Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DSM Wins Production Contract With Shire

by Michael McCoy
April 13, 2009 | A version of this story appeared in Volume 87, Issue 15

The British drug company Shire will close a plant in Owings Mills, Md., and transfer production of finished-dose drugs to DSM's contract manufacturing facility in Greenville, N.C. Products that will be moved during the next three years include Carbatrol, Intuniv, Lialda, Pentasa, and Vyvanse. DSM already produces Adderall XR and Fosrenol for Shire. According to local reports, the Shire closing will affect 260 employees.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.